Tumor suppressive microRNA-138 inhibits metastatic potential via the targeting of focal adhesion kinase in Ewing's sarcoma cells
Authors:
- 5 January 2016
- journal article
- research article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 48 (3) , 1135-1144
Abstract
Short non-coding RNAs, called microRNAs (miRNAs), regulate cell biology by affecting the expression of target genes. However, we know little about the miRNAs regulating the growth and progression of Ewing's sarcoma (ES). To identify possible oncogenic factors in ES, we used a microarray-based approach to profile the changes in the expression of miRNAs and the downstream mRNAs in five ES cell lines. One miRNA, miR‑138, was significantly downregulated, whereas the expression of focal adhesion kinase (FAK) was significantly upregulated in all tested ES cells. When miR‑138 was transfected into ES cell lines, the expression of FAK in these cells was greatly suppressed and inhibited the proliferation and mobility of ES cells. Overexpression of miR‑138 in vitro resulted in further inhibition of the cell cycle at the G1 phase and in the induction of anoikis, in a dose- and time-dependent manner. Moreover, miR‑138 overexpression in ES cells significantly suppressed the number of distant metastases in vivo. The data in the present study demonstrates for the first time a novel mechanism that regulates the expression of FAK via miR‑138 in ES cells.Keywords
This publication has 30 references indexed in Scilit:
- MicroRNA‐138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF‐1αInternational Journal of Cancer, 2013
- MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung CancerCellular Physiology and Biochemistry, 2013
- BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemiaOncogene, 2012
- Ewing sarcoma cells express RANKL and support osteoclastogenesisThe Journal of Pathology, 2011
- Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 TrialJournal of Clinical Oncology, 2010
- Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk PatientsJournal of Clinical Oncology, 2008
- The distinctive biology of cancer in adolescents and young adultsNature Reviews Cancer, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- MicroRNA expression profiles classify human cancersNature, 2005
- Small RNAs with big impactsNature, 2005